Holper Elizabeth M, Blair John, Selzer Faith, Detre Katherine M, Jacobs Alice K, Williams David O, Vlachos Helen, Wilensky Robert L, Coady Paul, Faxon David P
University of Chicago, Chicago, IL 60637, USA.
Am Heart J. 2006 Jan;151(1):69-75. doi: 10.1016/j.ahj.2005.03.053.
Patients with congestive heart failure (CHF) have higher rates of adverse outcomes after percutaneous coronary intervention (PCI). A comprehensive analysis of outcomes in patients with CHF in the current era has not been done. We studied the outcomes of patients with CHF who underwent PCI in the National Heart, Lung, and Blood Institute-sponsored Percutaneous Transluminal Coronary Angioplasty (PTCA) and Dynamic registries.
We evaluated demographic and angiographic characteristics and the clinical outcomes of patients with CHF in the Dynamic Registry and the PTCA Registry, excluding patients with acute myocardial infarction. In the Dynamic Registry, patients with CHF (n = 503) were compared with patients without CHF (n = 4194), and patients with CHF with a preserved ejection fraction (EF) (n = 134) were compared with patients with CHF who have a reduced EF (n = 199). The patients with CHF in the 1997 through 2001 Dynamic Registry (n = 236) were then similarly compared with patients with CHF in the earlier PTCA Registry (n = 117).
In the Dynamic Registry, compared with patients without CHF, patients with CHF had a higher-risk clinical and angiographic profile, and a higher mortality rate both inhospital (2.6% vs 0.4%, P < or = .001) and at 1 year (13.1% vs 3.0%, P < .001). Patients with reduced EF had higher inhospital mortality rates and a trend toward higher mortality at 1 year. The patients with CHF in the Dynamic Registry compared with those in the PTCA Registry had a higher risk profile yet had significantly higher procedural success rates and improved clinical outcomes.
Although CHF remains a strong predictor of adverse outcomes after PCI, significant improvement seen in the past decade is likely related to improved procedural techniques and improved medical therapy.
充血性心力衰竭(CHF)患者经皮冠状动脉介入治疗(PCI)后不良结局发生率较高。目前尚未对当代CHF患者的结局进行全面分析。我们在国立心肺血液研究所赞助的经皮腔内冠状动脉成形术(PTCA)和动态注册研究中,研究了接受PCI的CHF患者的结局。
我们评估了动态注册研究和PTCA注册研究中CHF患者的人口统计学和血管造影特征以及临床结局,排除急性心肌梗死患者。在动态注册研究中,将CHF患者(n = 503)与非CHF患者(n = 4194)进行比较,并将射血分数(EF)保留的CHF患者(n = 134)与EF降低的CHF患者(n = 199)进行比较。然后将1997年至2001年动态注册研究中的CHF患者(n = 236)与早期PTCA注册研究中的CHF患者(n = 117)进行类似比较。
在动态注册研究中,与非CHF患者相比,CHF患者具有更高风险的临床和血管造影特征,住院死亡率(2.6%对0.4%,P≤0.001)和1年死亡率(13.1%对3.0%,P<0.001)均更高。EF降低的患者住院死亡率更高,且1年死亡率有升高趋势。与PTCA注册研究中的患者相比,动态注册研究中的CHF患者风险更高,但手术成功率显著更高,临床结局有所改善。
尽管CHF仍然是PCI后不良结局的有力预测指标,但过去十年中观察到的显著改善可能与手术技术的改进和药物治疗的改善有关。